Extra studies in progress suggest that ARV-825 may also be effective in boosting the reaction to estrogen deprivation (aromatase inhibition), another part of normal of treatment in ER+ breast cancer. - "Our study exposed the essential position on the KLF16/MYC regulatory axis in modulating t